Date

Friday, 17 November 2023, 13:00 (CET) - 18:00 (CET)

Location

Online
European Medicines Agency, Amsterdam, the Netherlands

Event summary

The complexity of the pathophysiological mechanisms and clinical syndromes associated with long-COVID / post-acute sequelae condition (PASC) raises regulatory and methodological concerns related to the design of clinical trials to evaluate treatment and preventive approaches for these conditions.

This workshop brought together academia, industry, healthcare professionals, regulators, and patients groups to address these complexities and discuss topics such as appropriate patient population and efficacy endpoints in clinical trials.

Video recording

How useful do you find this page?